This site looks better in landscape mode

Developing a novel therapeutic for inflammatory diseases with a high unmet need

Developing a novel therapeutic for inflammatory diseases with a high unmet need

Over 2%

The burden to society of osteoarthritis in developed counties is more than 2% annual GDP

NEWS

APPA shows promise in age related diseases

Read More

NEWS

Interview with Longevity Technology

Read More

NEWS

OARSI 2023 Presentation

Read More

NEWS

 

APPA shows promise in age related diseases

Read More

 

Interview with Longevity Technology

Read More

 

OARSI 2023 Presentation

Read More